French insurtech Alan raises 480m at 5.5bn valuation with Belfius backing

French health insurance disruptor Alan has secured a €480 million Series G funding round, valuing the company at €5.5 billion just months after its previous €100 million raise, according to multiple reports published today. The Paris-based insurtech, which has rapidly expanded since its 2016 founding, now stands among Europe’s most valuable digital health ventures, with its valuation jumping from €4 billion in early 2026 to €5.5 billion following the latest capital injection.
The funding round was confirmed by Tech.eu and La Libre . Belgian bank Belfius, already an existing shareholder, is among the investors participating in the round, raising questions about the strategic benefits for the financial institution. The fresh capital will accelerate Alan’s expansion across France and into new European markets, where demand for digital-first health insurance continues to surge.
Alan’s growth trajectory reflects broader trends in European insurtech, where traditional insurers struggle to match the agility of tech-driven disruptors. The company’s valuation surge—from €4 billion to €5.5 billion in a matter of months—signals strong investor confidence in its subscription-based model, which combines AI-driven customer service with streamlined claims processing. Competitors and analysts will closely watch how Alan deploys the new funds, particularly as it eyes expansion into Germany, Spain, and Italy, where regulatory landscapes remain complex but increasingly favorable to digital health services.
The funding round comes at a time when European health insurers are under pressure to modernize, with rising healthcare costs and an aging population driving demand for cost-effective, user-friendly solutions. Alan’s ability to secure such a substantial investment underscores the sector’s potential, even as macroeconomic uncertainties persist. With the new capital, Alan plans to enhance its product offerings, invest in AI capabilities, and potentially explore strategic partnerships or acquisitions to consolidate its market position.
For Belfius and other backers, the high-stakes bet on Alan represents both an opportunity and a risk. While the insurtech’s rapid growth and innovative approach align with broader digital transformation trends, the company’s long-term profitability remains unproven. As Alan prepares to deploy the €480 million, all eyes will be on its next moves—whether it can sustain its valuation growth and whether its model can scale beyond France’s borders.
Follow us for live European news
- 2
- 2
- 1
- 1
- 1
- 1
- 1
- 1
5 further sources not geolocated





